VANCOUVER, BC — Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed… Read More
Augurex to attend British Society for Rheumatology 2025 Annual Meeting in Manchester, UK Highlighting biomarker-based diagnostic innovations for RA and axSpA VANCOUVER, BC – Augurex Life Sciences Corp., a leader… Read More
VANCOUVER, BC – Optigo Biotherapeutics (Optigo), a preclinical-stage biotechnology company focused on discovering and developing transformative therapies for blinding neovascular diseases, announced their presentation of data related to their long-acting… Read More
MGH-led study retrospectively analyzed 5,000 radiologist-reviewed screening exams using the company’s Genius AI® Detection Solution MARLBOROUGH, MA – Hologic, Inc. (Nasdaq: HOLX) will have a strong presence at the Society of… Read More
VICTORIA, BC – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to optimize drug delivery for applications with significant… Read More
